Covered recipient · General Payments record
OSCAR MARTINEZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$4,327.55
- Reported across 257 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $423.46 | 19 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Insulet Corporation | $146.17 | 2 |
| Lilly USA, LLC | $138.60 | 15 |
| VIVUS LLC | $124.97 | 1 |
| Acerta Pharma LLC | $13.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $13.72 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011404863 | CMS |
| Insulet Corporation | $15.89 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016938111 | CMS |
| Insulet Corporation | $130.28 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016938109 | CMS |
| Lilly USA, LLC | $14.34 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031982639 | CMS |
| Lilly USA, LLC | $6.11 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032118553 | CMS |
| Lilly USA, LLC | $12.92 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031982645 | CMS |
| Lilly USA, LLC | $0.96 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032072187 | CMS |
| Lilly USA, LLC | $15.96 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032118557 | CMS |
| Lilly USA, LLC | $1.08 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031970151 | CMS |
| Lilly USA, LLC | $16.49 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032003921 | CMS |
| Lilly USA, LLC | $5.28 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032044907 | CMS |
| Lilly USA, LLC | $14.76 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031932537 | CMS |
| Lilly USA, LLC | $6.10 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032003925 | CMS |
| Lilly USA, LLC | $15.39 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032118561 | CMS |
| Lilly USA, LLC | $6.53 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032044911 | CMS |
| Lilly USA, LLC | $5.46 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031970161 | CMS |
| Lilly USA, LLC | $15.78 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031970157 | CMS |
| Lilly USA, LLC | $1.44 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032094979 | CMS |
| VIVUS LLC | $124.97 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1030253101 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.